RK

Rajinder Kumar

Active Director Director DIN 08521558
DIN 08521558 First appointment Jul 2019 Primary industry Life Sciences
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2019
Shareholding value •••• Premium profile

About Rajinder Kumar

Data last updated:

Rajinder Kumar is a Director at Enzibeta Biotech Private Limited (since 2019). The company operates in Life Sciences. Enzibeta Biotech Private Limited reported revenue of ₹7,900 (FY 2025).

DIN 08521558
Primary Designation Director
Industry Life Sciences
First Appointment 25 Jul 2019
Oldest Company Age 10 yrs
Largest company Enzibeta Biotech Private Limited · ₹7,900 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Enzibeta Biotech Private Limited U74999TG2016PTC110635
Director25 Jul 20192016₹7,900 (FY 2025)Active

Board colleagues of Rajinder Kumar

NameDINCompanyDesignation
Prashant Gaur07547296Enzibeta Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Enzibeta Biotech Private Limited
Premium access

Shareholding and investment profile for Rajinder Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajinder Kumar

Rajinder Kumar currently holds 1 directorship: Enzibeta Biotech Private Limited (Director, since 25 Jul 2019, revenue ₹7,900 (FY 2025)).

Rajinder Kumar was first appointed on 25 Jul 2019 as Director at Enzibeta Biotech Private Limited.

The current boards of Rajinder Kumar's companies include Prashant Gaur (Enzibeta Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available